IL10 and B-cell chronic lymphocytic leukemia: As shown in Figure 5C, ibrutinib did not completely antagonize the ability of IL-10 to protect CLL cells from apoptosis (n=7) and to mediate signaling pathways through pSTAT3 and pERK (Figure 5D).